Kape Technologies Plc Just Missed EPS By 24%: Here's What Analysts Think Will Happen Next

March 24, 2022
Source: Shutterstock

Investors in Kape Technologies Plc (LON:KAPE) had a good week, as its shares rose 3.8% to close at UK£4.00 following the release of its full-year results. Results overall were not great, with earnings of US$0.094 per share falling drastically short of analyst expectations. Meanwhile revenues hit US$231m and were slightly better than forecasts. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

View our latest analysis for Kape Technologies

AIM:KAPE Earnings and Revenue Growth March 24th 2022

Following the latest results, Kape Technologies' five analysts are now forecasting revenues of US$619.7m in 2022. This would be a substantial 169% improvement in sales compared to the last 12 months. Statutory earnings per share are predicted to leap 297% to US$0.26. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$620.0m and earnings per share (EPS) of US$0.27 in 2022. The analysts seem to have become a little more negative on the business after the latest results, given the small dip in their earnings per share numbers for next year.

It might be a surprise to learn that the consensus price target was broadly unchanged at UK£4.99, with the analysts clearly implying that the forecast decline in earnings is not expected to have much of an impact on valuation. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. Currently, the most bullish analyst values Kape Technologies at UK£5.73 per share, while the most bearish prices it at UK£4.24. This is a very narrow spread of estimates, implying either that Kape Technologies is an easy company to value, or - more likely - the analysts are relying heavily on some key assumptions.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. It's clear from the latest estimates that Kape Technologies' rate of growth is expected to accelerate meaningfully, with the forecast 169% annualised revenue growth to the end of 2022 noticeably faster than its historical growth of 31% p.a. over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 13% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Kape Technologies to grow faster than the wider industry.

The Bottom Line

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Kape Technologies. Fortunately, they also reconfirmed their revenue numbers, suggesting sales are tracking in line with expectations - and our data suggests that revenues are expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. At Simply Wall St, we have a full range of analyst estimates for Kape Technologies going out to 2024, and you can see them free on our platform here..

Before you take the next step you should know about the 3 warning signs for Kape Technologies (1 is potentially serious!) that we have uncovered.

Valuation is complex, but we're helping make it simple.

Find out whether Kape Technologies is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis